Table 1.
Exploratory cohort (n = 105) | P value | Validation cohort (n = 297) | P value | |||
---|---|---|---|---|---|---|
CRC patients n = 76 | Healthy controls n = 29 | CRC patients n = 159 | Healthy controls n = 138 | |||
Age (yr) | ||||||
≤ 55 | 12 | 6 | 0.474 | 29 | 35 | 0.137 |
> 55 | 64 | 23 | 130 | 103 | ||
Gender | ||||||
Male | 42 | 15 | 0.745 | 105 | 72 | 0.015 |
Female | 34 | 14 | 54 | 66 | ||
Diagnosis (ICD) and disease stage | ||||||
C18 | – | – | ||||
Stage I | 12 | 11 | ||||
Stage II | 12 | 22 | ||||
Stage III | 10 | 31 | ||||
Stage IV | 4 | 19 | ||||
C19 | – | – | ||||
Stage I | 2 | 1 | ||||
Stage II | 2 | 12 | ||||
Stage III | 4 | 10 | ||||
Stage IV | 3 | 8 | ||||
C20 | – | – | ||||
Stage I | 5 | 18 | ||||
Stage II | 9 | 15 | ||||
Stage III | 7 | 6 | ||||
Stage IV | 6 | 6 |
ICD International Classification of Diseases, C18 malignant neoplasm of the colon, C19 malignant neoplasm of the rectosigmoid, C20 malignant neoplasm of the rectum. P value for Pearson’s χ2 test